Grow your business safely with SELARL PHARMACIE TERRAUBE SCREMIN

All the information you need about SELARL PHARMACIE TERRAUBE SCREMIN to develop and secure your business in France

S HOME > CORPORATES > SELARL PHARMACIE TERRAUBE SCREMIN > BALANCE SHEET ( 2017-03-13)

THE LIST OF BALANCE SHEET : SELARL PHARMACIE TERRAUBE SCREMIN

CORPORATEBOBACCESTABLISHMENTSMANAGERSFINANCE
Deposit Confidentiality closing date document
2022-06-03 Public 2021-09-30 Complete
2021-10-29 Public 2020-09-30 Complete
2021-02-18 Partially confidential 2019-09-30 Complete
2019-07-11 Partially confidential 2018-09-30 Complete
2019-01-10 Public 2017-09-30 Complete
2017-03-13 Partially confidential 2016-09-30 Complete
NameSELARL PHARMACIE TERRAUBE SCREMIN
Siren805366903
Closing2016-09-30
Registry code 3201
Registration number 527
Management number2014D00260
Activity code 4773Z
Closing date n-12015-09-30
Duration Fiscal year 12
Duration Fiscal year n-109
Filing date2017-03-13
Modification01 Annual accounts entered with accounting inconsistencies at document source
Balance sheet typeC : Complete
Currency codeEUR
ConfidentialityPartially confidential
Address32800 Eauze
1 - Assets (balance sheet)Gross amount year NAmortization year NNet year NNet year N-1
AH Goodwill 1 428 500.00 1 428 500.00 1 428 500.00
AP Buildings 2 980.00 339.00 2 641.00 2 980.00
AR Technical installations, industrial equipment and tools 32 969.00 12 418.00 20 550.00 32 969.00
AT Other tangible assets 92 019.00 28 225.00 63 793.00 92 019.00
BD Other fixed assets 716.00 716.00 716.00
BJ TOTAL (I) 1 557 185.00 40 984.00 1 516 200.00 1 557 185.00
BT Goods 122 688.00 122 688.00 122 688.00
BX Customers and related accounts 37 252.00 37 252.00 37 252.00
BZ Other receivables 13 123.00 13 123.00 13 123.00
CF Cash and cash equivalents 107 487.00 107 487.00 107 487.00
CH Prepaid expenses 2 014.00 2 014.00 2 014.00
CJ TOTAL (II) 282 566.00 282 566.00 282 566.00
CO Grand total (0 to V) 1 839 752.00 40 984.00 1 798 767.00 1 839 752.00
2 - Liabilities (balance sheet)Amount year NAmount year N-1
DA Share or individual capital 500 000.00 500 000.00
DD Legal reserve (1) 321.00 321.00
DG Other reserves 6 109.00 6 109.00
DI RESULTS FOR THE YEAR (Profit or Loss) 64 301.00 64 301.00
DL TOTAL (I) 570 732.00 570 732.00
DU Loans and Debts from Credit Institutions (3) 693 584.00 693 584.00
DV Miscellaneous Loans and Financial Debts (4) 371 715.00 371 715.00
DX Trade payables and related accounts 93 793.00 93 793.00
DY Tax and social security liabilities 68 941.00 68 941.00
EC TOTAL (IV) 1 228 035.00 1 228 035.00
EE Grand total (I to V) 1 798 767.00 1 798 767.00
EG Accrued income and payables due within one year 595 737.00 595 737.00
5 - Fixed assets increase - decreaseGross value at beginning of year - Item by itemRevaluation - DisposalsAcquisition - Gross value at year-end
0G ACQUISITIONS Total General Total 1 556 823.00 1 556 823.00
I3 DECREASES Total Financial Fixed Assets 716.00
I4 DECREASES Grand Total 1 557 185.00
IY DECREASES Total Tangible Fixed Assets 127 969.00
LN ACQUISITIONS Total Tangible Fixed Assets 127 803.00 127 803.00
LQ ACQUISITIONS Total Financial Fixed Assets 520.00 520.00
6 - Depreciation Amount at beginning of yearIncrease: allocation for the yearDiminution repriseYear-end amount
0N DEPRECIATION Grand Total 19 085.00 22 199.00 300.00 19 085.00
QU DEPRECIATION Total Tangible Fixed Assets 19 085.00 22 199.00 300.00 19 085.00
8 - Receivables and payablesGross amountAmount within 1 yearAmount 1 to 5 yearsAmount more than 5 years
8B Suppliers and Related Accounts 93 793.00 93 793.00 93 793.00
8K Other liabilities (including liabilities related to repo transactions) 371 716.00 371 716.00 371 716.00
VH Loans with a maturity of more than one year at origin 693 585.00 61 287.00 258 076.00 693 585.00
VK Loans repaid during the year 59 054.00 59 054.00
VS Prepaid expenses 2 014.00 2 014.00
VT TOTAL – STATEMENT OF RECEIVABLES 52 390.00 52 390.00 52 390.00
VY TOTAL – STATEMENT OF LIABILITIES 1 228 035.00 595 738.00 258 076.00 1 228 035.00

all companies in France

Complete and comprehensive database.